MetLife Investment Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $67.1K | Sell |
|
|||||
|
2025
Q2 | $80K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $241K | Hold |
|
|||||
|
2023
Q2 | $365K | Buy |
|
|||||
|
2023
Q1 | $274K | Hold |
|
|||||
|
2022
Q4 | $534K | Buy |
|
|||||
|
2022
Q3 | $492K | Hold |
|
|||||
|
2022
Q2 | $437K | Buy |
|
|||||
|
2022
Q1 | $453K | Buy |
|
|||||
|
2021
Q4 | $241K | Hold |
|
|||||
|
2021
Q3 | $298K | Hold |
|
|||||
|
2021
Q2 | $291K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $97.2K | Hold |
|
|||||
|
2018
Q3 | $191K | Hold |
|
|||||
|
2018
Q2 | $263K | Buy |
|
|||||
|
2018
Q1 | $174K | Hold |
|
|||||
|
2017
Q4 | $244K | Buy |
|